Mr Geofrey John
Higher Degree by Research Candidate
School of Pharmacy and Biomedical Sciences
College of Health
PhD researcher with expertise in cancer biology, immunology, and advanced therapeutic modalities. Experienced in in-vivo animal models, radiotherapy, and bioinformatics analysis. Published in high-impact journals; skilled in scientific communication, teaching, and collaborative research. Seeking opportunities to contribute to innovative cancer treatment strategies and academic excellence.
| Date | Position | Institution name |
|---|---|---|
| 2023 - 2025 | Research Fellow | Advanced Centre for Treatment, Research and Education in Cancer |
| Language | Competency |
|---|---|
| English | Can read, write, speak, understand spoken and peer review |
| Hindi | Can read, speak and understand spoken |
| Tamil | Can read, write, speak, understand spoken and peer review |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2022 - 2025 | JSS University | India | MPharm |
| 2018 - 2022 | JSS University | India | BPharm |
| Date | Title | Institution | Country |
|---|---|---|---|
| 2023 - 2024 | Dissertation Trainee | Advanced Centre for Treatment, Research and Education in Cancer | India |
| Year | Citation |
|---|---|
| 2025 | Raj, J. A. T., Shah, J., Ghanekar, S., John, G., Goda, J. S., & Chatterjee, A. (2025). Pharmacological and therapeutic innovation to mitigate radiation-induced cognitive decline (RICD) in brain tumor patients. CANCER LETTERS, 620, 20 pages. WoS3 |
| 2025 | Raj, J. A. T., John, G., Ghanekar, S., Thiruselvan, G. K., Shah, J., Ande, D., . . . Goda, J. S. (2025). RAGE signaling pathway in glioblastoma and cognitive decline: Insights into inflammatory mechanisms and therapeutic implications. Brain Research, 1869, 16 pages. Scopus2 WoS2 |
| 2025 | Arun, B., John, G., & Raman, R. (2025). MicroRNA Signatures: Illuminating Minimal Residual Disease Monitoring in Juvenile Myelomonocytic Leukemia - A Review. JOURNAL OF HEMATOLOGY, 14(2), 43-55. WoS1 Europe PMC1 |
| 2025 | Sandhbor, P., John, G., Bhat, S., & Goda, J. S. (2025). Immune response recalibration using immune therapy and biomimetic nano-therapy against high-grade gliomas and brain metastases. Asian Journal of Pharmaceutical Sciences, 20(2), 32 pages. Scopus22 WoS18 |
| 2025 | Palkar, P. A., John, G., Chekuri, G., Chatterjee, A., Kunwar, A., & Goda, J. S. (2025). Radioprotectors & mitigators in radiation therapy: Harnessing diverse pathways for optimizing clinical outcomes. INDIAN JOURNAL OF MEDICAL RESEARCH, 162(3), 343-366. WoS1 |
| 2024 | Sandbhor, P., Palkar, P., Bhat, S., John, G., & Goda, J. S. (2024). Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy. NANOSCALE, 16(13), 6330-6364. WoS52 |
| - | John, G., Ghanekar, S., Dominic, D., Gawde, J. R., Dora, T., Chopra, S. J., & Goda, J. S. (2026). Dynamic γ-H2AX response in blood lymphocytes for prediction of radiotherapy induced bladder toxicity in cervical cancer patients. The Indian Journal of Medical Research, 163, 11-18. |
Connect With Me
External Profiles
